Zura Bio Limited
ZURA
$4.75
$0.000.00%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 4.79% | -12.80% | 8.31% | -28.01% | 34.19% |
| Total Depreciation and Amortization | 7.14% | 27.27% | 22.22% | 80.00% | 66.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -200.96% | -36.82% | 2.92% | 30.02% | -77.44% |
| Change in Net Operating Assets | -1,475.63% | 105.15% | -241.49% | 10,908.00% | -100.98% |
| Cash from Operations | -44.25% | 3.66% | -44.90% | -2.21% | -91.47% |
| Capital Expenditure | 46.88% | -113.33% | 69.39% | -8.89% | -246.15% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 46.88% | -113.33% | 69.39% | -8.89% | -246.15% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 466.67% | -- | -100.00% | 2,591.50% | -96.39% |
| Repurchase of Common Stock | -- | 100.00% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | 72.83% | -717.78% |
| Cash from Financing | -243,933.33% | 108.82% | -100.66% | 706.91% | -115.69% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -91.37% | 3.77% | -171.19% | 49.42% | -5,180.63% |